Document Type: Original Article
Department of Radiology, Hahnemann University Hospital, Philadelphia, PA, and Johns Hopkins Hospital, Baltimore, USA
Department of Radiation Oncology and Medical Oncology, Hahnemann University Hospital, Philadelphia, PA, and Johns Hopkins Hospital, Baltimore, USA
Tc-99m MIBI has recently been used in the functional imaging of various tumors. This prospective study was performed to evaluate the role of Tc-99m MIBI imaging at the time of the initial staging, assessment of treatment response, follow-up studies and survaillance in Hodgkin’s and non-Hodgkin’s Iymphoma. 25 patients (14 with Hodgkin’s and 11 with non-Hodgkin’s Iymphoma) underwent 32 studies. The patient’s age range wa 19-73 years, with a mean age of 41.7 years. All patients underwent whole body planar imaging following intravenous injection of 20-25 mCi Tc-99m MIBI. Comparative imaging with 3 mCi Tl-201 and 10 mCi Ga-67 injection was done. Clinical, radiographic and biopsy correlation was obtained in all cases.